DELAYED ELIMINATION OF ENOXAPARINE IN PATIENTS WITH CHRONIC RENAL-INSUFFICIENCY

被引：139

作者：

CADROY, Y

POURRAT, J

BALADRE, MF

SAIVIN, S

HOUIN, G

MONTASTRUC, JL

VERNIER, I

BONEU, B

机构：

[1] CHU TOULOUSE,SERV PHARMACOL MED & CLIN,INSERM,U317,F-31073 TOULOUSE,FRANCE

[2] HOP PURPAN,UNITE PHARMACOCINET,F-31059 TOULOUSE,FRANCE

[3] HOP PURPAN,SERV NEPHROL,F-31059 TOULOUSE,FRANCE

[4] FAC MED TOULOUSE,F-31073 TOULOUSE,FRANCE

来源：

关键词：

LOW MOLECULAR WEIGHT HEPARIN; PHARMACOKINETICS; CHRONIC RENAL FAILURE;

D O I：

10.1016/0049-3848(91)90141-I

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：385 / 390

页数：6

共 10 条

[1] Boneu B, 1990, Baillieres Clin Haematol, V3, P531, DOI 10.1016/S0950-3536(05)80017-4
[2] BONEU B, 1989, THROMB HAEMOSTASIS, V62, P524
[3] BRIANT L, 1989, THROMB HAEMOSTASIS, V61, P348
[4] DISAPPEARANCE OF CIRCULATING ANTI-XA ACTIVITY AFTER INTRAVENOUS-INJECTION OF STANDARD HEPARIN AND OF A LOW-MOLECULAR WEIGHT HEPARIN (CY-216) IN NORMAL AND NEPHRECTOMIZED RABBITS
CARANOBE, C
BARRET, A
GABAIG, AM
DUPOUY, D
SIE, P
BONEU, B
[J]. THROMBOSIS RESEARCH, 1985, 40 (01) : 129 - 133
[5] FOLLEA G, 1986, HAEMOSTASIS, V16, P147
[6] THE ANTITHROMBOTIC ACTIVITY AND PHARMACOKINETICS OF ENOXAPARINE, A LOW-MOLECULAR WEIGHT HEPARIN, IN HUMANS GIVEN SINGLE SUBCUTANEOUS DOSES OF 20 TO 80 MG
FRYDMAN, AM
BARA, L
LEROUX, Y
WOLER, M
CHAULIAC, F
SAMAMA, MM
[J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 28 (07) : 609 - 618
[7] LOW-MOLECULAR-WEIGHT HEPARIN HALF-LIFE IS PROLONGED IN HEMODIALYZED PATIENTS
GOUDABLE, C
THAT, HT
DAMANI, A
DURAND, D
CARANOBE, C
SIE, P
BONEU, B
[J]. THROMBOSIS RESEARCH, 1986, 43 (01) : 1 - 5
[8] KAMPMANN J, 1974, ACTA MED SCAND, V196, P517
[9] PALM M, 1987, THROMB HAEMOSTASIS, V58, P932
[10] HEPARIN PHARMACOKINETICS - INCREASED REQUIREMENTS IN PULMONARY-EMBOLISM
SIMON, TL
HYERS, TM
GASTON, JP
HARKER, LA
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 1978, 39 (01) : 111 - 120